Skip to main content
Equibles

Farther Finance Advisors, LLC

Position in LEXX — Lexaria Bioscience Corp.

CIK 1992825 SAN FRANCISCO, CA
Back to LEXX Full portfolio

Position in LEXX

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$96
-$33 QoQ
Shares Held
11
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 31 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LEXX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,711,819 across 284 Biotechnology names. LEXX ranks #258 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,922 $2,444,905
2 MRNA
Moderna, Inc.
 15,429 $1,080,492
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 12,088 $985,292
4 HALO
Halozyme Therapeutics, Inc.
 11,241 $879,833
5 EXEL
Exelixis, Inc.
 14,171 $771,044
6 REGN
Regeneron Pharmaceuticals, Inc.
 1,075 $670,305
7 VKTX
Viking Therapeutics, Inc.
 15,171 $591,820
8 BMRN
Biomarin Pharmaceutical Inc
 7,871 $450,378

All Filings in LEXX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $96 172
2026-03-31 $129 166
2025-12-31 $102 166
2025-09-30 $158 166
2025-06-30 $144 166
2025-03-31 $283 166
2024-12-31 $348 166
2024-09-30 $506 166
2024-06-30 $461 166
2024-03-31 $602 166
2023-12-31 $207 166
2023-09-30 $166 166
2023-06-30 $121 166
2023-03-31 $451 166